These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 805252)

  • 21. Inhibitory effect of actinomycin D on the inductio of rat mammary tumors by in vitro exposure to 7,12-dimethylbenz(a)anthracene.
    Tominaga T; Tei N; Taguchi T; Takeda Y
    Cancer Res; 1975 Jul; 35(7):1698-701. PubMed ID: 805663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic variability of chemically induced primary rat mammary tumors.
    Dolezalová V; Rejthar A; Sugár J; Tóth J; Vermousek I
    Neoplasma; 1989; 36(1):103-12. PubMed ID: 2495492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strain difference in neoplastic response to DMBA powder dusted onto mammary tissues between Wistar/Furth and Copenhagen strains of rats.
    Kusunose N; Shoji T; Tsubura A; Yamamoto M; Morii S
    Jpn J Exp Med; 1990 Oct; 60(5):291-7. PubMed ID: 2127811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship of terminal duct hyperplasia to mammary carcinoma in 7,12-dimethylbenz(alpha)anthracene-treated LEW/Mai rats.
    Purnell DM
    Am J Pathol; 1980 Feb; 98(2):311-24. PubMed ID: 6243869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there any association between elevated serum prolactin level and mammary adenocarcinoma induced by 7,12-dimethylbenz(alpha)anthracene.
    Feuer G; Kellen JA; Kovacs K
    Res Commun Chem Pathol Pharmacol; 1975 Jul; 11(3):435-44. PubMed ID: 807960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of age on the histopathogenesis of 7,12-dimethylbenz(a)-anthracene-induced mammary tumors in the Lewis rat.
    Haslam SZ
    Int J Cancer; 1980 Sep; 26(3):349-56. PubMed ID: 6793523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of caffeine and/or coffee consumption on the initiation and promotion phases of 7,12-dimethylbenz(a)anthracene-induced rat mammary gland tumorigenesis.
    Welsch CW; DeHoog JV; O'Connor DH
    Cancer Res; 1988 Apr; 48(8):2068-73. PubMed ID: 3127044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inheritance of a genetic factor from the Copenhagen rat and the suppression of chemically induced mammary adenocarcinogenesis.
    Isaacs JT
    Cancer Res; 1988 Apr; 48(8):2204-13. PubMed ID: 3127047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferation of ductal outgrowths by carcinogen-induced rat mammary tumors in gland-free mammary fat pads.
    Rivera EM; Vijayaraghavan S
    J Natl Cancer Inst; 1982 Aug; 69(2):517-25. PubMed ID: 6810006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal exposure to diethylstilbestrol: ovarian-independent growth of mammary tumors induced by 7,12-dimethylbenz[a]anthracene.
    Boylan ES; Calhoon RE
    J Natl Cancer Inst; 1981 Apr; 66(4):649-52. PubMed ID: 6785506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperplastic lesions in the mammary glands of Sprague-Dawley rats after 7,12-dimethyl-benz[a]anthracene treatment.
    Beuving LJ; Faulkin LJ; DeOme KB; Bergs VV
    J Natl Cancer Inst; 1967 Sep; 39(3):423-9. PubMed ID: 6047995
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship of hormones to inhibition of mammary tumor development by underfeeding during the "critical period" after carcinogen administration.
    Sylvester PW; Aylsworth CF; Meites J
    Cancer Res; 1981 Apr; 41(4):1384-8. PubMed ID: 6783295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid induction of mammary cancer by repeated subcutaneous injection of the trans-3,4-dihydrodiol of 7,12-dimethylbenz[a]anthracene in the female Sprague-Dawley rat.
    Horn J; Lehner AF; Flesher JW
    Cancer Lett; 2005 Apr; 220(2):155-60. PubMed ID: 15766590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion.
    Russo J; Wilgus G; Russo IH
    Am J Pathol; 1979 Sep; 96(3):721-36. PubMed ID: 112872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
    Ting AY; Kimler BF; Fabian CJ; Petroff BK
    Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathogenesis of 7,12-diemthylbenz(a)anthracene-induced rat mammary tumors.
    Haslam SZ; Bern HA
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):4020-4. PubMed ID: 410031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat.
    Carter CA; Milholland RJ; Shea W; Ip MM
    Cancer Res; 1983 Aug; 43(8):3559-62. PubMed ID: 6407750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell cycle-related hormone carcinogen interaction during chemical carcinogen induction of nodule-like mammary lesions in organ culture.
    Lin FK; Banerjee MR; Crump LR
    Cancer Res; 1976 May; 36(5):1607-14. PubMed ID: 178426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA adduct formation by 7,12-dimethylbenz[a]anthracene and its noncarcinogenic 2-fluoro analogue in female Sprague-Dawley rats.
    Daniel FB; Joyce NJ
    J Natl Cancer Inst; 1983 Jan; 70(1):111-8. PubMed ID: 6401826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fasting-refeeding stimulates the development of mammary tumors induced by 7,12-dimethylbenz[a]anthracene.
    Sesca E; Premoselli F; Binasco V; Bollito E; Tessitore L
    Nutr Cancer; 1998; 30(1):25-30. PubMed ID: 9507509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.